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Altered polarity and expression of H-ATPase without ultra- Mutations of the CLCN5 gene, located on chromo-
structural changes in kidneys of Dent’s disease patients. some Xp11.22, cause Dent’s disease, which is a renal tubu-
Background. Dent’s disease is a proximal tubule (PT) disor- lar disorder characterized by low-molecular-weight (60der characterized by low-molecular-weight proteinuria (LWMP)
kD) proteinuria (LMWP), albuminuria, hypercalciuria,that may be associated with hypercalciuria, nephrocalcinosis,
nephrocalcinosis, nephrolithiasis, and renal failure [1–3].and renal failure. It is caused by inactivating mutations of
the renal chloride channel ClC-5, which colocalizes with the Other renal proximal tubular defects, including aminoacid-
vacuolar H-ATPase in PT cells and -type intercalated cells. uria, phosphaturia, glycosuria, kaliuresis, and impairment
Examinations of knockout mice have established the role of
of urinary acidification, may also occur in some patientsClC-5 in PT endocytosis, but the consequences of ClC-5 muta-
[1, 3]. CLCN5, which has a predominantly renal expres-tions on the polarity of H-ATPase and other plasma mem-
brane proteins remain unknown. sion in humans and rodents, belongs to the CLCN family
Methods. We have studied renal biopsies from eight patients of mammalian voltage-gated chloride channel genes that
with Dent’s disease, due to inactivating ClC-5 mutations, by encode proteins (ClC-1 to ClC-7, ClC-Ka and ClC-Kb)light and electron microscopy, and by immunohistochemical
with 18 transmembrane domains [4]. These chloride chan-staining. All patients exhibited LMWP, and renal function
nels are important for the control of membrane excitabil-ranged from normal to end-stage renal failure.
Results. Light microscopy revealed either normal renal ar- ity, transepithelial transport, and possibly regulation of
chitecture or glomerulosclerosis, tubular dedifferentiation and cell volume [5]. Heterologous expression of wild-type
atrophy, and mild interstitial fibrosis. Focal, hyaline casts,
ClC-5 in Xenopus oocytes results in chloride conduc-sometimes calcified, were identified at all stages. Electron mi-
tance, which is markedly reduced or abolished by thecroscopy did not reveal any ultrastructural abnormalities in
PT cells, and the endocytic apparatus was apparently normal. ClC-5 mutations of Dent’s disease [2, 5, 6].
However, immunohistochemical studies demonstrated a con- The segmental distribution of ClC-5 in the adult hu-
sistent inversion of H-ATPase polarity in PT cells to a basolat- man kidney includes the proximal tubule (PT), the thickeral distribution contrasting with its apical location in the nor-
ascending limb (TAL) of Henle’s loop and the -typemal kidney. This inversion of polarity was specific for H-ATPase
intercalated cells (IC) of the collecting duct [7]. At theand did not affect distribution of aminopeptidase, megalin, and
Na/K-ATPase. Furthermore, apical H-ATPase expression subcellular level, ClC-5 has been localized to PT apical
was absent in -type intercalated cells. endosomes together with the vacuolar H-ATPase, there-
Conclusion. ClC-5 mutations are associated with modifica-
by suggesting that it may contribute to the chloridetions in the polarity and expression of H-ATPase, but not
conductance necessary for endosomal acidification andultrastructural alterations in PT cells. These findings help fur-
ther understanding of the role of ClC-5 and the pathophysiol- function [7–9]. Reabsorption of low-molecular-weight
ogy of Dent’s disease. proteins by the PT depends on receptor-mediated endo-
cytosis and transport to the acidic vacuolar-lysosomal
system [10]. Consequently, a loss of ClC-5 function mayKey words: chloride channel, ClC-5, intercalated cells, low-molecular-
weight proteinuria, proton pump, proximal tubule. decrease chloride influx in the endocytic vesicles and
thereby prevent the dissipation of the positive chargeReceived for publication February 19, 2002
generated by the electrogenic H-ATPase that is neces-and in revised form July 25, 2002, and September 25, 2002
Accepted for publication November 7, 2002 sary for the provision of the acidic environment [11].
This would lead to impaired endosomal acidification and 2003 by the International Society of Nephrology
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inefficient reabsorption (i.e., LMWP), which is a consis-
tent feature of Dent’s disease [1, 3]. This hypothesis is
supported by two independent studies of ClC-5–deficient
mice, which were shown to have a defect in receptor-
mediated endocytosis associated with LMWP and PT
dysfunction [12, 13]. These abnormalities in the ClC-5
knockout mice were not associated with gross defects in
renal architecture, although the possibility remains that
there may be more specific ultrastructural abnormalities.
We have investigated renal histology and ultrastructure
and immunolocalized several plasma membrane pro-
teins, including the vacuolar H-ATPase, in the kidneys
of patients with Dent’s disease, all of whom had proven
inactivating ClC-5 mutations.
METHODS
Patients and controls, mutational analysis of CLCN5
Renal biopsy samples were obtained from eight male
patients with Dent’s disease belonging to seven distinct
pedigrees. Four of these patients originated from Univer-
sity of Tokyo (Tokyo, Japan), three from State University
of New York (Syracuse, NY, USA), and one from Uni-
versity College, London (UK). Seven of these eight pa-
tients have been previously reported [2, 14–17] to harbor
a ClC-5 mutation (Table 1) and include two nonsense
(R648X, R28X), one missense (G506E), two acceptor
splice-site mutations (intron 5, 132-172 deletion and ag
to gg), and two deletions. Mutation analysis was per-
formed in the fourth Japanese patient (# 4, Table 1),
using CLCN5 specific primers for polymerase chain reac-
tion (PCR) amplification as previously described [15, 17].
This new mutation resulted from the deletion of a T
(nucleotide 483) at codon 64 within exon 3 of CLCN5,
leading to a frameshift and a stop codon (TAG) at codon
71 (Fig. 1). The four Japanese patients had a normal
acid-base status at the time of renal biopsy (arterial blood
pH range, 7.38 to 7.41; plasma bicarbonate range, 23.5
to 25 mEq/L). The age at renal biopsy in patients with
Dent’s disease ranged from 6 to 54 years. The biopsy
from patient # 8 was obtained at time of renal tranplanta-
tion for end-stage renal disease (ESRD). The principal
clinical characteristics of the patients at the time of diag-
nostic evaluation are given in Table 1. Plasma creatinine
was normal in three Japanese patients (age 11 years)
and slightly increased (1.1 mg/dL) in patient # 1 (14
years old). All patients tested had / proteinuria
and LMWP. Hypercalciuria was present in five of seven
patients assessed. Nephrocalcinosis was detected (von
Kossa’s staining) in one patient 6 years old and in all
patients older than 10 years. An additional biopsy was
obtained at age 65 from the heterozygote carrier mother
of patient # 5; this female carrier had renal failure and
a long clinical history of hypertension. Samples from
normal human kidney (renal transplant biopsies at time
of surgery, N  3; tumor-free pole of kidneys removed
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Fig. 1. Detection of the deletional mutation in exon 3 of CLCN5 in patient # 4. DNA sequence analysis of the affected male II-1 (A ) revealed
a T (nucleotide 483) deletion at codon 64, thus causing a frameshift that resulted in a missense peptide with a stop codon (TAG) at codon 71 (B
and C). The mother I-1 (A) is heterozygous for the wild-type and mutant alleles (B). The mutations were confirmed by DNA sequence analysis
of additional polymerase chain reaction (PCR) products. This DNA sequence abnormality was not detected in 110 alleles from 56 unrelated,
normal Japanese individuals (54 females and 2 males), thereby indicating that this is not a common sequence polymorphism (data not shown).
Individuals shown are male (box); female (circle); unaffected (open); carrier (half-filled); patient (filled).
for polar carcinoma, N 2) or immunoglobulin A (IgA) in paraffin. Six micrometer sections were cut and stained
with Masson’s trichrome. Calcium deposits in paraffin-nephropathy (N 1) and minimal-change disease (N 1)
were used for control experiments. The use of these hu- embedded sections were visualized with von Kossa’s stain-
ing [13]. For electron microscopy, samples were fixed inman samples has been approved by the University of
Louvain Ethical Review Board. 2.5% glutaraldehyde and postfixed in osmium tetroxide,
before embedding in Epon. Ultrathin sections (80 nm),
Processing for microscopy contrasted with uranyl acetate and lead citrate, were
examined through a Zeiss EM 109 (Carl Zeiss, Inc., NewFor light microscopy, samples were either frozen in
liquid nitrogen or fixed for 6 hours at 4C in 4% formal- York, NY, USA) or a Philips CM12 (Philips, Eindhoven,
The Netherlands) electron microscope.dehyde in 0.1 mol/L phosphate buffer, then embedded
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Subcellular fractionation Immunohistochemistry
Immunostaining in human renal biopsies was per-A sample from normal human kidney cortex was im-
mersed in ice-cold phosphate-buffered saline (PBS), and formed using immunoperoxidase, as described [7, 19].
Primary antibodies included the monoclonal antibodycarefully minced in 1 mm3 fragments that were homoge-
nized in 0.25 mol/L sucrose, 3 mmol/L imidazole, pH 7.0, against vacuolar H-ATPase [18]; rabbit polyclonal anti-
bodies against aquaporin-1 (AQP-1) (Alamone, Jerusa-by a Potter-Thomas homogenizer. Postnuclear particles
(denoted mitochondria-lysosomes-peroxysomes [MLP] lem, Israel); rabbit polyclonal antibodies against amino-
peptidase N [19]; sheep antibodies against megalin [21];fraction) were first retrieved by differential sedimenta-
tion. For this purpose, nuclei and cell debris were re- a mouse monoclonal antibody against the Na/H ex-
changer type 3 (NHE3) (Chemicon, Temecula, CA, USA);moved by sedimentation at 10,000g 	 minute, and this
pellet was washed twice by sedimentation-resedimenta- and a mouse monoclonal antibody IVF12 against human
anion exchanger type 1 (AE1) [22]. Following incubationtion under identical conditions. The pooled supernatants
were further pelleted in a fixed-angle rotor (Ti 50, Beck- in 0.3% H2O2 (30 minutes) and 10% normal serum in
PBS (20 minutes) at room temperature, rehydrated sec-man, Palo Alto, CA, USA) at 6 	106g 	 minute. After
high-speed supernatant was removed, the high-speed tions were incubated successively with primary antibod-
ies; biotinylated goat antirabbit or horse antimouse IgG;pellet was resuspended in 5 mL homogenization buffer
by a Dounce homogenizer. This suspension was layered avidin-biotin peroxidase (ABP) complex; and, after wash-
ing, aminoethylcarbazole (Vector, Burlingame, CA, USA).over a linear sucrose gradient (1.05 to 1.30 g/mL in den-
sity) and equilibrated in a vertical rotor (vTi 50, Beck- Sections were examined under a Leica DMR coupled to
a Leica MPS60 photomicrographic system (Leica, Heer-man) at 24	 106g	minute. Fourteen fractions of equal
brugg, Switzerland). The specificity of the immunolabel-volume were collected from the bottom (# 1, densest;
ing was confirmed by incubation without primary or sec-# 13-14, loading zone) and analyzed for density (refrac-
ondary antibody; or with nonimmune rabbit or mousetorimetry) and protein content using the BCA assay
IgG (Vector).(Pierce Chemical, Rockford, IL, USA). Aliquots of
equal volume were analyzed by Western blotting.
RESULTSWestern blotting
Light microscopy examinationSodium dodecyl sulfate-polyacrylamide gel electro-
phoresis (SDS-PAGE) and immunoblotting were per- Light microscopy examination (Fig. 2) showed that
the Japanese patients (Fig. 2 A to C), who were allformed as previously described [7]. Briefly, the extracts
were solubilized by heating (95C for 3 minutes) in sam- younger than 15 years old, had normal glomeruli and
well-preserved tubules. The interstitium was free of in-ple buffer [1.5% SDS, 10 mmol/L Tris-HCl, pH 6.8, 0.6%
dithiothreitol (DTT), and 6% (vol/vol) glycerol], before filtrate or fibrosis and arteries were normal. Hyaline casts
were detected within the lumen of Henle’s loop (Fig. 2 Bseparation on 7.5% acrylamide gels and transfer to nitro-
cellulose. The membranes were stained with Ponceau and C). The deposits were focal, without any interstitial
change, and were not detected in the distal convolutedRed (Sigma Chemical Co., St. Louis, MO, USA) to check
the efficiency of transfer, before blocking and incubation tubules or collecting ducts. They presented a red-to-
purple color gradient, compatible with early calcium de-with the primary antibody diluted in [2% bovine serum
albumin (BSA), 50 mmol/L phosphate buffer, 150 mmol/L position (Fig. 2C). Mild interstitial fibrosis was observed
in patient # 6 (31 years old and from the United States)NaCl, 0.05% Tween 20, pH 7.4], at 4C for 16 to 18 hours.
The primary antibodies included a monoclonal antibody (Fig. 2D). The kidney of patient # 7 (6 years old and
from the United States) contained 14/58 glomeruli with(E11) raised against the 31 kD subunit of the vacuolar
H-ATPase [18]; an affinity-purified antibody raised complete or partial hyalinosis, the others showing slightly
increased cellularity (Fig. 2E). Patients # 6 and # 7 dis-against the N-terminus of human ClC-5 [13]; rabbit poly-
clonal antibodies against aminopeptidase N [19]; a mono- played mild tubular atrophy and hyaline casts located in
the outer medulla (Fig. 2 D to F). Some of the castsclonal antibody against the1-subunit of Na/K-ATPase
(Upstate Biotechnology, Lake Placid, NY, USA); and a were calcified, as indicated by von Kossa’s staining (Fig.
2G). A mild interstitial fibrosis, predominantly locatedmonoclonal antibody against the lysosomal protein lyso-
some-associated membrane protein 1 (LAMP1) [20]. The near arcuate arteries at the corticomedullary junction,
was also detected. The kidney from the heterozygotemembranes were washed, incubated for 1 hour at room
temperature with the appropriate peroxidase-labeled an- female carrier had moderate or severe tubular atrophy
and epithelial cell degeneration with many hyaline caststibody (Dako, Glostrup, Denmark), and visualized after
exposure to enhanced chemiluminescence (Amersham, in Henle’s loop, as well as a severe fibrosis throughout
the biopsy (data not shown).Arlington Heights, IL, USA).
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Fig. 2. Light microscopy findings in patients with Dent’s disease. (A ) Representative section of the kidney cortex in patient # 2, with intact
glomeruli, well-preserved tubular structures and arteries, and absence of fibrosis. (B and C ) Outer medulla of patient # 4, in which hyaline casts
are identified within the lumen of Henle’s loop (B). The gradient in dye affinity in the boxed field in (B) is shown at higher magnification in (C).
(D ) Inner cortex–outer medulla junction in patient # 6 showing mild interstitial fibrosis and foci of tubular basement membrane hyalinization and
hyaline casts. (E to G ) Representative sections from the inner cortex (E, G) and medulla (F) of patient # 7. (E) shows an almost hyalinized
glomerulus, and a hyaline cast presenting a typical dye gradient within an atrophic tubule (arrow). (F) shows large areas of atrophic tubules with
inflammatory infiltrate and hyaline cats. Calcifications within the interstitium are evidenced in black by von Kossa’s staining (G). (H to J) Sections
from patient # 8. Medium-power view (H) of the end-stage kidney with interstitial nephritis features, adventitial fibrous thickening of blood vessels,
and hyaline casts within atrophic tubules (arrows). von Kossa’s staining of a step section (I) demonstrates calcification of the hyaline globules. (J)
illustrates at low-power large, confluent calcifications within atrophic areas. Masson’s trichrome, (A) to (F), and (H); von Kossa’s staining, (G),
(I), and (J). Bars in (A), (B), (D) to (G), 50 
m; (C), 10 
m; (H) and (I), 100 
m; (J), 500 
m.
Moulin et al: The kidney in Dent’s disease1290
Fig. 3. Conventional electron microscopy from patients with Dent’s disease. Patient # 3 has the entire CLCN5 gene deleted. Proximal tubule
(PT) epithelial cells with normal morphology (A) that included a well-developed brush border, endosomal apparatus, numerous mitochondria,
and thin basement membrane. Higher magnification illustrates a tall and well-differentiated brush border with preserved intercellular junctions
(B), and normal abundance of apical endosomes (C). Intercellular junctions (D ) are seen between PT epithelial cells in patient # 4. Cell boundaries
are interdigitated, and well-differentiated tight junctions are evident. Bars in (A), 2 
m; (B), 0.5 
m; (C), 0.3 
m; (D), 1 
m.
The ESRD kidney from patient # 8 (54 years old and vacuolar H-ATPase recognized by Western blotting a
from the United Kingdom) was characterized by severe single band at 31 kD (Fig. 4, left lane). Upon equilibra-
sclerosis, with the glomeruli being hyalinized or present- tion of these particles in linear sucrose gradients, the
ing a thickened capsule, and diffuse tubular epithelial cell brush-border marker enzyme, aminopeptidase, the baso-
degeneration or atrophy (Fig. 2H). In addition, several lateral marker enzyme, Na/K-ATPase, and the lyso-
concretions of different size were observed within atrophic somal membrane marker, LAMP1, showed a broad dis-
tubular lumen or interstitium, corresponding to calcifi- tribution with a large peak at fractions # 6–9, # 7–10, and
cations (Fig. 2 I and J). # 7–10, respectively, whereas ClC-5 was restricted to a
narrow peak at fractions # 7–8 (Fig. 4, fractions # 1–14).Ultrastructural analyses
Particles containing the 31 kD subunit of H-ATPase
Electron microscopy survey could be performed on essentially codistributed with ClC-5 at fractions # 7–8,
the samples from the four Japanese and two patients and further showed a minor shoulder at fraction # 9
from the United States, and three controls. Extensive corresponding to the peak of lysosomes. These data
analysis of patient # 3, who had a complete deletion of would indicate that, in the human kidney cortex, the bulk
CLCN5, showed normal PT cells, including a thick and of H-ATPase is associated with ClC-5 in endosomes.
well-differentiated brush border, coated invaginations
and numerous endosomes of various sizes in the apical Immunocytochemistry
area, normal lysosomes, as well as mitochondria that
The locations of well-characterized plasma membranewere abundant and elongated, and well-differentiated
proteins were studied by immunohistochemistry usingtight junctions (Fig. 3). Similar observations were made
frozen sections from the four Japanese patients within all patients. Nonspecific findings in PT cells, that in-
Dent’s disease and four control biopsies. Preliminarycluded dilation of the endoplasmic reticulum and appar-
experiments established the validity of immunostainingently smaller subapical areas containing few endosomes,
and confirmed the apical distribution of H-ATPase,were also observed in control samples.
megalin, and aminopeptidase, as well as the basolateral
Subcellular distribution of vacuolar H-ATPase in the distribution of the 1 subunit of Na/K-ATPase in con-
human kidney: Western blotting trol biopsies (Fig. 5). In particular, H-ATPase was lo-
cated in the subapical area of PT, and in the apical poleIn postnuclear particles from the normal human kid-
ney cortex, antibodies against the 31 kD subunit of the of -type intercalated cells (IC) within collecting ducts
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Fig. 4. Subcellular distribution of the vacuo-
lar H-ATPase in the humen kidney cortex.
Western blotting analysis. Postnuclear parti-
cles of a human kidney cortex (MLP, left lane)
were equilibrated in a linear sucrose gradient
(densest fractions are # 12, loading zone
fractions are # 1314). Equal volumes of the
indicated fractions were further analyzed by
Western blotting for the indicated constit-
uents. Particles containing the 31 kD vacuolar
H-ATPase codistribute with ClC-5 at frac-
tions # 7 and # 8 (**), and further showed a
minor shoulder at fraction # 9 corresponding
to the peak of lysosomes as indicated by
LAMP1 expression.
Fig. 5. Immunostaining for plasma membrane proteins in control renal biopsies. Immunostaining for the 31 kD subunit of vacuolar H-ATPase
(A) confirms its subapical distribution in proximal tubule (PT) cells as well as in the apical pole of -type intercalated cells (arrowheads). Megalin
(B ) and aminopeptidase (C ) are also located in the apical pole of PT epithelial cells, whereas the 1 subunit of the Na/K-ATPase is located
at the basolateral domain of the cells (D ). Bar is 25 
m.
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Fig. 6. Immunostaining for plasma membrane proteins in the kidneys of patients with Dent’s disease. Serial sections (A to D) from patient # 3
with a deletion encompassing the entire CLCN5 gene. Immunostaining shows a complete inversion of polarity for H-ATPase in proximal tubule
(PT) cells (A), contrasting with the preserved apical polarity of megalin (B) and aminopeptidase (C), and the preserved polarity of Na/K-
ATPase at the basolateral side of the cell (D). Adjacent sections from patient # 1 (E and F ) and patient # 2 (G to H ) confirm the inversion of
polarity of H-ATPase (E and G) contrasting with the preserved apical polarity of megalin (F and H). Immunostaining for the anion exchanger
AE1 and H-ATPase in patient # 3 (I and J ) and patient # 2 (K and L ). The basolateral staining for AE1 identifies -type intercalated cells (*)
within collecting duct profiles (I and K). No apical staining for H-ATPase can be detected in these cells (J and L) (*), whereas the basolateral
staining in adjacent PT cells is preserved (L) (arrowheads). Bar is 40 
m.
(Fig. 5A). The distribution of these markers was similar tion of H-ATPase in PT cells (Fig. 6A), similar to that
of Na/K-ATPase (Fig. 6D), and this contrasted within all control biopsies examined. However, a similar anal-
ysis of the serial sections from Japanese patient # 3, the preserved apical distribution of megalin (Fig. 6B)
and aminopeptidase (Fig. 6C), as well as the apical polar-characterized by a complete deletion of CLCN5, re-
vealed unexpected findings. Immunostaining in this pa- ization of NHE3 and the mixed apical and basolateral
distribution of the water channel AQP-1 (data not shown).tient with Dent’s disease revealed a basolateral distribu-
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The selective inversion of the apical polarity of H- uria, mild phosphaturia, glycosuria, and polyuria [12, 13].
Such PT dysfunction, when it occurs as a primary renalATPase was confirmed in the four patients analyzed, in-
cluding patient # 1 (C-terminal deletion; Fig. 6 E and F), Fanconi syndrome in humans, may be associated with a
partial loss or shortening of the brush border [27]. Thepatient # 4 (T deletion at 483; Fig. 6 G and H) and patient
# 2 (not shown). The prolonged fixation times and areas absence of structural and ultrastructural changes in the
PT cells of patients with Dent’s disease and ClC-5 knock-of extended tubular damage did not allow us to perform
such reliable immunostaining experiments in the paraf- out mice is therefore unusual. The ClC-5 knockout mice
have been studied at a relatively young age [13], and itfin-embedded samples from patients # 6 and # 7.
In addition to PT cells, ClC-5 and H-ATPase are is possible that subtle alterations in the endocytic appara-
tus of PT cells will appear with aging. However, this isknown also to colocalize in -type IC, which can be
independently identified by basolateral labeling of the unlikely to be the explanation in patients # 1 and # 6, who
were 14 and 31 years of age, respectively (Table 1). Oneanion exchanger AE1 [23]. Strong basolateral staining
for AE1 identified -type IC in the collecting ducts of alternative possibility for the lack of morphologic alter-
ations in the endocytic apparatus could be that the losspatients # 3 (Fig. 6I) and # 2 (Fig. 6K). However, these
cells showed no apical staining for H-ATPase, which of ClC-5 does not affect the expression level of basic com-
ponents of the endocytic apparatus such as clathrin andcould nevertheless be clearly detected at the basolateral
pole of adjacent PT cells (Fig. 6 J and L). Rab5 [10, 11], but specifically alters components that close-
ly codistribute and perhaps physically interact with it.
Our observations of H-ATPase distribution in the
DISCUSSION
human kidney (normal versus Dent’s disease) are consis-
This study provides the first description of renal archi- tent with the latter hypothesis. In the normal human
tecture in patients with Dent’s disease that have proven kidney, the vacuolar H-ATPase colocalizes with ClC-5
ClC-5 mutations. At the light microscope, the kidneys in the apical membrane area of PT cells as well as in-type
are characterized by hyaline casts and early calcifications. IC of the collecting ducts [7]. Furthermore, immunoblot
Despite generalized PT dysfunction and LMWP, the ul- analyses revealed that H-ATPase codistributes with
trastructure of PT cells is surprisingly normal, including ClC-5 in subcellular fractions compatible with endo-
their tight junctions, brush border, and apical areas, that somes (Fig. 4). Dent’s disease, which is caused by a loss
contain the endocytic apparatus. However, molecular ab- of functional ClC-5, is reflected by an inverted polarity
normalities are detected in cells coexpressing H-ATPase of H-ATPase in PT cells and its apparent loss in the
and ClC-5. There is a specific inversion of H-ATPase -type IC (Fig. 6). These changes are specific for the
polarity in PT cells and a loss of apical expression of vacuolar H-ATPase, as the polarity of other plasma
H-ATPase in the -type IC of the collecting ducts. membrane proteins in the same cells remains unaltered.
The light microscopy studies revealed progressive, yet Furthermore, these changes are independent of the type
nonspecific lesions, that include glomerular hyalinosis, of mutation. For example, a complete CLCN5 deletion
tubular cell degeneration or atrophy, and mild interstitial (patient # 3) and a limited loss of the 98 amino acids at the
fibrosis, confirming earlier observations on isolated cases C-terminus (patient # 1) resulted in identical alterations.
[1, 24]. However, in addition to these nonspecific find- These modifications in the polarity and/or expression
ings, our studies show that these kidneys also have hya- of a nonmutated protein point to physical interaction
line casts that are sometimes calcified (Fig. 2). The casts between the C-terminus of ClC-5 and H-ATPase, that
were invariably detected, even at the early stage and in would be essential for proper targeting (e.g., within PT
otherwise normal kidneys. Their location in the outer cells) or even stability (e.g., within IC) of H-ATPase.
medulla, presumably in the loop of Henle, as well as In contrast with the alterations observed in the kidney
their distinct tinctorial affinity, suggests that they may of patients with Dent’s disease, it is puzzling to note that
represent the first manifestations of nephrocalcinosis the distribution and polarity of H-ATPase is apparently
[25]. This process was undoubtly accelerated in some unaltered in knockout mice lacking ClC-5 [12, 13]. In
patients, such that calcifications were identified in a 6-year- absence of technical differences (similar fixation proce-
old patient (Fig. 2). dures and antibodies were used in both species), it is
LMWP is the most consistent feature of patients with tempting to speculate that the species difference may
Dent’s disease [1, 3]. It has been demonstrated in the reflect the complexity of the multisubunit vacuolar H-
two ClC-5 knockout mice [12, 13], but not in a ribozyme ATPase [28]. The complete identity of all the compo-
antisense mouse model of reduced ClC-5 expression [26]. nents of the H-ATPase has yet to be elucidated, but
The LMWP reflects a severe impairment in receptor- there are at least 13 subunits that present tissue- and
mediated endocytosis in PT cells due to a loss of ClC-5 segment-specific expression [28]. For instance, different
function. The impaired endocytosis is paralleled by other expression levels and segmental distribution of the
116 kD accessory (a) subunit isoforms have been docu-manifestations of PT dysfunction, including aminoacid-
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